TNB Tech Minute: Meta’s Hit New AI Agent Is Facing Backlash
Summary
Meta’s Muse AI agents face scrutiny over security risks and Amazon’s unauthorized access block. In biotech, Invada Biosciences doubles its valuation to $2 billion to fund weight-loss and dermatology drug trials. Meanwhile, Finnish defense firm Sensof Fusion raises $344 million via IPO to expand its anti-drone technology, which is deployed in Ukraine and the Middle East.
Topics discussed
Intro and Meta AI agent privacy concerns
Amazon blocks Meta's Muse agent access
Invada Biosciences doubles valuation to $2B
Finnish defense firm SensoFusion IPO plans
Outro and Schwab Advisor Services ad
Listen ad-free on Castria